Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-03-05
2000-05-23
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, A61K 31517
Patent
active
060666404
ABSTRACT:
Hydroxy-halo quinazolines for the augmentation of mast cell anti-microbial activity are disclosed.
REFERENCES:
Barriere, S. L. et al. (Feb. 1995), Critical Care Medicine, 23(2):376-393 "An overview of mortality risk prediction in sepsis.".
Echtenacher, B. et al. (May 2, 1996), Nature, 381:75-77 "Critical protective role of mast cells in a model of acute septic peritonitis."
Goodman, P.A. et al. (Jul. 10, 1998), The Journal of Biological Chemistry, 273(28):17742-17748 "Role of Tyrosine Kinases in Induction of the c-jun Proto-oncogne in Irradiated B-lineage Lymphoid Cells."
Malaviya, R. et al. (1994), Journal of Immunology, 152(4):1907-1914 "Mast Cell Phagocytosis of FimH--Expressing Enterobacteria."
Malaviya, R. et al. (1995), Methods in Enzymology, 253:27-43 "Interaction of Bacteria with Mast Cells."
Malaviya, R. et al. (1996), Journal of Immunology, 156(4):1490-1496 "Mast Cells Process Bacterial Ags through a Phagocytic Route for Class I MHC Presentation to T Cells."
Malaviya, R. et al. (Apr. 1994), J. Clin. Invest., 93:1645-1653 "Mast Cell Degranulation Induced by Type 1 Fimbriated Escherichia coli in Mice."
Malaviya, R. et al. (Mar. 5, 1993), The Journal of Biological Chemistry, 268(7):4939-4944 "Reversible Translocation of 5-Lipoxygenase in Mast Cells upon IgE/Antigen Stimulation."
Malaviya, R. et al. (May 2, 1996), Nature, 381:77-80 "Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF--.alpha.."
Qureshi, R. et al. (Sep. 15, 1988), The Journal of Immunology, 141(6):2090-2096 "The Role of Mast Cells in Thioglycollate--Induced Inflammation."
Schifferli, D. M. et al. (Nov. 1988), Antimicrobial Agents and Chemotherapy, 32(11):1609-1613 "Bacterial Adhesion: Modulation by Antibiotics with Primary Taragets Other than Protein Synthesis."
Sher, A. (Sep. 23, 1976), Nature, 263:334-336 "Complement-dependent adherence of mast cells to schistosomula."
Sher, A. et al. (1979), Laboratory Investigation, 41(6):490-499 "Complement Receptors Promote the Phagocytosis of Bacteria by Rat Peritoneal Mast Cells."
Sher, A. et al.(Sep. 1983), The Journal of Immunology, 131(3):1460-1464 "Mechanisms of Protective Immunity Against Schistosoma Mansoni Infection in Mice Vaccinated with Irradiated Cercariae. IV. Analysis of the Role of IgE Antibodies and Mast Cells."
Tewari, R. et al. (Feb. 5, 1993), The Journal of Biological Chemistry, 268(4):3009-3015 "Neutrophil Activation by Nascent FimH Subunits of Type 1 Fimbriae Purified from the Periplasm of Escherichia coli."
van den Broek, P.J. (Mar.-Apr. 1989), Reviews of Infectious Diseases, 11(2):213-245 "Antimicrobial Drugs, Microorganisms, and Phagocytes."
Xu, L. et al. (1993), Prostaglandins, 45:385-398 "Effect of Culture Conditions on Mast Cell Eicosanoid Synsthesis."
Malaviya Ravi
Uckun Fatih M.
Hughes Institute
Spivack Phyllis G.
LandOfFree
Hydroxy-halo-quinazolines for augmentation of mast cell bacteric does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxy-halo-quinazolines for augmentation of mast cell bacteric, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxy-halo-quinazolines for augmentation of mast cell bacteric will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837282